This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Piers Gaffney, PhD
Chief Scientific Officer & VP of Research at Exactmer
Speaker

Profile

Piers, a PhD holder from Kings College London, specializes in oligonucleotide and phospholipid synthesis, with a PostDoc from UCL. With expertise in phosphorylated metabolites, he led chemistry in the Livingston Group from 2012 to 2019, focusing on innovative research. Named on 6 patents in Nanostar Sieving, he currently heads the Chemistry team at Exactmer, spearheading groundbreaking research and development efforts.

Agenda Sessions

  • Fully Liquid Phase, Membrane-Assisted Oligonucleotide Synthesis

    10:10am